{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-040837","form_type":"8-K","ticker":"RCKT","cik":"0001281895","company_name":"ROCKET PHARMACEUTICALS, INC.","filed_at":"2024-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.458443+00:00","generated_at":"2026-05-31T05:23:31.547486+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Rocket Pharmaceuticals appoints Dr. Mikael Dolsten to board","bullets":["Dr. Mikael Dolsten appointed to board effective September 9, 2024.","Dolsten is Chief Scientific Officer and President, Pfizer R&D since July 2023.","Granted options to purchase 27,545 shares (vesting over 3 years) and 22,988 shares (vesting in 1 year) at closing market price.","Entered standard indemnification agreement with the company.","No arrangements with other persons or family relationships with directors/officers."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-040837","json":"https://secwatch.observer/filing/0001140361-24-040837.json","markdown":"https://secwatch.observer/filing/0001140361-24-040837.md","text":"https://secwatch.observer/filing/0001140361-24-040837.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124040837/0001140361-24-040837-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124040837/ef20035750_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:23:31.547486+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ac6287b5aa","claim":"Dr. Mikael Dolsten was appointed as Director at ROCKET PHARMACEUTICALS, INC..","evidence_excerpt":"appointed Dr. Mikael Dolsten, M.D., Ph.D. to the Board, effective September 9, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124040837/0001140361-24-040837-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}